共 50 条
- [1] A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic CancerAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 772 - 776Cardin, Dana B.Thota, RamyaGoff, Laura W.Berlin, Jordan D.Jones, Clyde M.Ayers, Gregory D.Whisenant, Jennifer G.Chan, Emily
- [2] Second- and third-line treatment of metastatic breast cancer with gemcitabineEUROPEAN JOURNAL OF CANCER, 1998, 34 : S44 - S44Brodowicz, TMöslinger, RHerscovici, VVaclavik, IWiltschke, CKubista, EZielinski, C
- [3] FOLFIRI regimen as second- and third-line chemotherapy for metastatic biliary tract or pancreatic cancer.JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Loioia, Fernanda NavarroGuedes Camandaroba, Marcos PedroOliveira Fernandes, Viviane TeodoroRodrigues Pereira, Augusto Akikubo
- [4] Second- and third-line therapy in gastric cancer/new options for therapyONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 128 - 128Schmalenberg, H.
- [5] Randomized phase II study of perifosine in combination with capecitabine versus capecitabine alone in patients with second- or third-line metastatic colon cancerJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Vukelja, S.Richards, D.Campos, L. T.Bedell, C.Hagenstad, C.Hyman, W.Letzer, J.Gardner, L.Sportelli, P.Nemunaitis, J.
- [6] Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical CancerNEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (01): : 44 - 55Vergote, IgnaceGonzalez-Martin, AntonioFujiwara, KeiichiKalbacher, ElsaBagameri, AndreaGhamande, SharadLee, Jung-YunBanerjee, SusanaMaluf, Fernando CotaitLorusso, DomenicaYonemori, KanVan Nieuwenhuysen, ElsManso, LuisWoelber, LinnWestermann, AnnekeCovens, AllanHasegawa, KoseiKim, Byoung-GieRaimondo, MiriamBjurberg, MariaCruz, Felipe MeloAngelergues, AntoineCibula, DavidBarraclough, LisaOaknin, AnaGennigens, ChristineNicacio, LeoTeng, Melinda Siew LengWhalley, ElizabethSoumaoro, IbrahimaSlomovitz, Brian M.
- [7] Bevacizumab in the treatment of metastatic colorectal cancer (mCRC) in second- and third-line settingsSEMINARS IN ONCOLOGY, 2006, 33 (05) : S15 - S18Giantonio, Bruce J.
- [8] Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal CancerJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4394 - 4400Bendell, Johanna C.Nemunaitis, JohnVukelja, Sasha J.Hagenstad, ChristopherCampos, Luis T.Hermann, Robert C.Sportelli, PeterGardner, LesaRichards, Donald A.
- [9] A prospective phase II trial of vinorelbine plus oxaliplatin in second- or third-line metastatic triple-negative breast cancerCANCER RESEARCH, 2013, 73Wang, Z.Zhang, J.Wang, L.Hu, X.Wang, B.Cao, J.Lv, F.Zhen, C.Zhang, S.Shao, Z.
- [10] Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non-Small-Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 369 - 372Ramalingam, Suresh S.Owonikoko, Taofeek K.Behera, MadhusmitaSubramanian, JanakiramanSaba, Nabil F.Kono, Scott A.Gal, Anthony A.Sica, GabrielHarvey, R. DonaldChen, ZhengjiaKlass, Carmen M.Shin, Dong M.Fu, HaianSun, Shi-yong R.Govindan, RamaswamyKhuri, Fadlo R.